Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
Liensinine raw Powder CAS 2586-96-1 Liensinine
Product Overview:
Nelumbo nucifera Gaeertn, a nymphaeaceae plant, is an important Chinese herbal medicine. Its leaves can clear summer heat and remove dampness and hemostasis, and its stem can widen the middle and regulate qi, etc. The green germ of its mature seeds, lotus seed heart, has the effect of clearing the heart and regulating qi fire and strengthening the essence and blood
Liensinine raw Powder CAS 2586-96-1 Liensinine Attributes
CAS:2586-96-1
MF:C37H42N2O6
MW:610.74
EINECS:683-151-0
Specification: 99% min Liensinine
Sample:Liensinine Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:white
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
Liensinine raw Powder CAS 2586-96-1 Liensinine Details
Liensinine Usage and Synthesis.
Liensinine has many cardiovascular activities such as lowering blood pressure, slowing down heart rate, inhibiting myocardial contractility and anti-arrhythmia. Liensinine can also reduce the lipid peroxidation damage and protect the myocardial injury caused by ischemia reperfusion in rats. Liensinine can reduce the production of lipid peroxide MDA and enhance the activities of SOD and GSH-Px in serum, thereby reducing a series of cell damage reactions caused by free radicals. It can also effectively increase the content of local ATP in the ischemic area, reduce the content of lactic acid, and significantly improve the energy metabolism of cerebral ischemic tissue, thus improving the neurological dysfunction of cerebral ischemia reperfusion rats and narrowing the scope of cerebral infarction.
Uses of Liensinine.
Liensinine can reduce the production of lipid peroxide MDA, enhance the activity of serum SOD and GSH-Px, and thus reduce the series of cell damage reactions caused by free radicals. It can also effectively increase the content of local ATP in the ischemic area, reduce the content of lactic acid, and significantly improve the energy metabolism of cerebral ischemic tissue, thus improving the neurological dysfunction of cerebral ischemia reperfusion rats and narrowing the scope of cerebral infarction.
Preparation of Liensinine.
Product Method of Liensinine.
